JS
James J Schutz

James J Schutz insider trades: Sonoma Pharmaceuticals (SNOA) stock purchases

Sonoma Pharmaceuticals Last trade Mar 8, 2018 31 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2007
2
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 8, 2018SNOA↑ Buy$10K
Nov 30, 2017SNOA↑ Buy$2K
Nov 29, 2017SNOA↑ Buy$2K
Nov 24, 2017SNOA↑ Buy$1K
Aug 10, 2017SNOA↑ Buy$5K
Mar 3, 2017SNOA↑ Buy$5K
Dec 8, 2016SNOA↑ Buy$5K
Aug 15, 2016OCLS↑ Buy$5K
Feb 25, 2016OCLS↑ Buy$5K
Nov 17, 2014OCLS↑ Buy$11K
Aug 16, 2013OCLS↑ Buy$12K
Nov 9, 2012OCLS↑ Buy$10K
Aug 9, 2010OCLS↑ Buy$35K
Dec 9, 2009OCLS↑ Buy$36K
Aug 12, 2009OCLS↑ Buy$10K
Dec 7, 2007OCLS↑ Buy$46K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About James J Schutz's insider trades

James J Schutz is an insider at Sonoma Pharmaceuticals (SNOA). Since Dec 7, 2007, James has reported 16 open-market purchases worth $201K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (14 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNOA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.